Top Markets
#1 MowCat MowCat +49.38%
#2 aPriori aPriori +27.96%
#3 Velvet Velvet +25.02%
#4 Fake World Assets Fake World Assets +24.52%
#5 Block Street Block Street +18.77%
#6 Perle Perle +16.39%
#7 Bermuda Shorts Bermuda Shorts +14.68%
#8 Derive Derive +14.64%
#9 Biconomy Biconomy +14.11%
#10 DUSK Network DUSK Network +13.11%
Coin of the day
MowCat MowCat
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc.

GTTX
Rankning i aktier #34710
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in... GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Aktiekurs
$0.10409799
Senast synkroniserad: 2025-02-03
Marknadsvärde
$5.07M
Förändring (1 dag)
16.43%
Förändring (1 år)
0.00%
Land
CA
Handel GeneTether Therapeutics Inc. (GTTX)

Kategori

Healthcare
Aktiekurshistorik för GeneTether Therapeutics Inc. (GTTX)
Högsta slutkurs: $0.10 den 2025-02-01

Lägsta slutkurs: $0.51 den 2022-03-01
Aktiekurshistorik för GeneTether Therapeutics Inc. från 2022 till 2026
Årlig aktiekursutveckling
År Prestanda
2025 120.05%
2024 200.43%
2023 -74.49%
2022 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE